BRAoVO™ Schwannoma Gene panel

Genetic panel for hereditary schwannoma and nerve sheath tumour risk.

Test description

Testing of genes associated with inherited schwannoma and nerve sheath tumour syndromes in patients with schwannomas orsuggestive clinical features.

Test information

Test name

BRAoVOTM Schwannoma Gene panel

Clinical indication

Testing for patients with multiple orrecurrent schwannomas, early‑onset disease, or features suggestive of ahereditary schwannoma syndrome. Results may assist with diagnosis, management,surveillance, and family risk assessment.

Gene(s)

LZTR1, NF1, NF2, PRKAR1A, SMARCB1

Method

Massively parallel sequencing

Turn around time

4 - 5 weeks

Medicare eligibility

None

Price

$499

Test request form

Cancer genetics test request form preferred. Standard pathology request form accepted.

Sample type

Blood x 2

Collection type

EDTA

Special instructions

2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.

FAQ

No items found.

Resources

No items found.